Aurobindo Pharma gets NDA approval, stocks up
At 13:44 pm (IST),Aurobindo Pharma Ltd has lost by 0.2% to Rs580.70
Aurobindo Pharma Ltd has lost by 0.2% to Rs 580.70. The fast track integrated pharmaceutical company received the first tentative NDA approval for fixed dose combination drug product containing Lamivudine + Zidovudine + Nevirapine Tablets (NDA) used in the treatment of HIV-1 infection. The scrip has touched an intra-day high of Rs 597 and a low of Rs 574 and has recorded volumes of over 41 thousand shares on NSE.


![[Most Recent Charts from www.kitco.com]](../../charts/metals/gold/t24_au_en_uskg_4.gif)